CAPRICOR THERAPEUTICS, INC. Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants of $22.43 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-17.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants · last filed 2023-03-17
- CAPRICOR THERAPEUTICS, INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2020-09-30 was $193.79K.
- CAPRICOR THERAPEUTICS, INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2020-06-30 was $5.34M.
- CAPRICOR THERAPEUTICS, INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2020-03-31 was $86.13K.
- CAPRICOR THERAPEUTICS, INC. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2021 was $22.43K, a 99.61% decline from fiscal 2020.
- CAPRICOR THERAPEUTICS, INC. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2020 was $5.69M.
| Period end | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 3 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 6 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 9 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 12 month |
|---|---|---|---|---|
| 2021-12-31 | $22.43K 10-K · filed 2023-03-17 | |||
| 2020-12-31 | $5.69M 10-K · filed 2022-03-11 | |||
| 2020-09-30 | $193.79K 10-Q · filed 2021-11-12 | $5.54M derived: sum of 2 quarters · filed 2021-11-12 | $5.62M derived: sum of 3 quarters · filed 2021-11-12 | |
| 2020-06-30 | $5.34M 10-Q · filed 2021-11-12 | $5.43M derived: sum of 2 quarters · filed 2021-11-12 | ||
| 2020-03-31 | $86.13K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |